info icon

Personal history of medical treatment

Z21_PERSONAL_HISTORY_MEDICAL_TREAT

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Z92
  • Cause of death: ICD-10 Z92

2 out of 7 registries used, show all original rules.

325

4. Check minimum number of events

None

325

5. Include endpoints

None

325

6. Filter based on genotype QC (FinnGen only)

325

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[8-9]

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 325 190 135
Unadjusted period prevalence (%) 0.06 0.06 0.06
Median age at first event (years) 58.19 52.50 66.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
278
Matched controls
2780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z92.1
ICD-10 Finland
Personal history of long-term (current) use of anticoagulants
+∞
68.6
63
*
Z92.4
ICD-10 Finland
Personal history of major surgery, not elsewhere classified
+∞
55.1
51
*
Z92.8
ICD-10 Finland
Personal history of other medical treatment
+∞
46.1
43
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
30.8
29
*
Z92.0
ICD-10 Finland
Personal history of contraception
+∞
30.8
29
*
Z92.3
ICD-10 Finland
Personal history of irradiation
+∞
27.6
26
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
5.6
26.6
88
211
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
124.9
21.9
23
*
Z92.2
ICD-10 Finland
Personal history of long-term (current) use of other medicaments
226.3
20.9
21
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
31.7
20.0
26
9
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.4
19.9
36
33
127
Kela drug reimbursment
Transplant complication
214.6
19.8
20
*
B01AA03
ATC
warfarin; systemic
4.0
18.0
82
261
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.5
17.9
30
23
Z96.1
ICD-10 Finland
Presence of intraocular lens
15.5
14.3
23
16
L04AA06
ATC
mycophenolic acid; systemic
45.0
14.3
17
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
56.3
14.0
16
*
Z92.5
ICD-10 Finland
Personal history of rehabilitation measures
+∞
13.7
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
13.2
80
311
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
13.2
57
170
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
9.8
13.1
26
29
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
12.9
88
371
J01MA12
ATC
levofloxacin; systemic
3.3
12.7
72
264
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.1
12.7
21
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
12.6
83
342
I48.2
ICD-10 Finland
Chronic atrial fibrillation
14.3
12.1
20
15
C03CA01
ATC
furosemide; systemic
2.8
12.1
93
420
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
48.9
12.0
14
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
48.9
12.0
14
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
11.9
126
685
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
17.4
11.8
18
11
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
13.4
11.8
20
16
L04AD01
ATC
ciclosporin; systemic
31.6
11.8
15
5
WX002
NOMESCO Finland
Sedation and analgesia
3.1
11.7
71
273
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.5
11.6
30
51
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
11.5
11
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
11.3
11.5
21
20
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
26.3
11.3
15
6
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.5
11.2
29
49
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
11.2
132
752
ZXE00
NOMESCO Finland
One hour or less
2.5
11.2
125
691
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.0
10.9
30
55
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.1
10.7
66
256
A06AD11
ATC
lactulose; oral
3.4
10.6
55
189
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
10.4
61
227
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
10.3
96
478
Z2221
NOMESCO Finland
Medical doctor
2.5
10.3
96
478
ZXD05
NOMESCO Finland
Urgent procedure
2.4
10.2
105
552
L01BB02
ATC
mercaptopurine; oral
17.5
10.0
15
9
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
17.5
10.0
15
9
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.6
9.9
83
386
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
9.9
68
282
J01FF01
ATC
clindamycin; systemic
2.5
9.8
90
443
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.8
9.8
42
124
J01DB01
ATC
cefalexin; oral
2.7
9.7
232
1818
L03AA02
ATC
filgrastim; parenteral
12.0
9.7
17
15
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
9.7
117
663
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
9.6
94
474
N03AX16
ATC
pregabalin; oral
2.7
9.5
72
316
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
103.4
9.5
10
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
103.4
9.5
10
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
103.4
9.5
10
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
9.4
9
*
Z3231
NOMESCO Finland
Registered nurse
2.4
9.3
93
477
Z01.7
ICD-10 Finland
Laboratory examination
3.4
9.2
46
154
C07AB07
ATC
bisoprolol; oral
2.2
9.2
131
794
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.8
9.0
38
110
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
9.0
23
39
Z3226
NOMESCO Finland
Physiotherapist
2.7
9.0
66
283
H02AB09
ATC
hydrocortisone; systemic
8.1
8.8
19
25
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.6
8.7
68
303
WX892
NOMESCO Finland
Monitored bed care
4.0
8.5
34
94
B01AB05
ATC
enoxaparin; parenteral
2.3
8.4
89
466
Z92.9
ICD-10 Finland
Personal history of medical treatment, unspecified
+∞
8.4
8
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
8.2
120
725
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.8
8.2
56
228
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.6
8.2
37
114
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.2
76
371
TAB00
NOMESCO Finland
Lumbar puncture
5.9
8.2
22
40
602
Kela drug reimbursment
Children's severe malnutrition
34.4
8.1
10
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
22.8
8.1
11
5
ZXA00
NOMESCO Finland
Right side
2.4
8.1
80
405
A46
ICD-10 Finland
Erysipelas
3.0
8.0
48
180
I50.9
ICD-10 Finland
Heart failure, unspecified
3.3
8.0
41
140
J01MA14
ATC
moxifloxacin; systemic
3.6
7.8
35
107
A02BC02
ATC
pantoprazole; systemic
2.1
7.8
177
1273
A11CC03
ATC
alfacalcidol; systemic
12.3
7.7
13
11
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.5
7.6
26
62
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
7.6
48
188
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.9
7.5
20
36
ZXA05
NOMESCO Finland
Left side
2.3
7.5
76
388
WX199
NOMESCO Finland
Other local analgesia
8.7
7.4
15
18
M79.6
ICD-10 Finland
Pain in limb
2.1
7.4
109
655
S97
ICPC
Chronic ulcer skin
6.1
7.4
19
33
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
7.4
24
55
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
7.3
7
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
7.3
7
*
XF402
NOMESCO Finland
ECG with work load test
3.2
7.3
40
140
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
7.3
30
86
R4110
NOMESCO Finland
Physiotherapy
2.2
7.3
82
438
N05CF01
ATC
zopiclone; oral
2.2
7.2
87
476
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.0
7.2
22
47
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
7.2
64
306
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
7.1
99
578
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.9
7.1
22
48
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
7.0
35
117
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
7.0
32
100
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
6.9
46
183
R50.9
ICD-10 Finland
Fever, unspecified
2.7
6.9
49
205
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
6.9
31
96
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
41.1
6.8
8
*
A12AA04
ATC
calcium carbonate; oral
23.2
6.7
9
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
6.6
71
369
L04AA01
ATC
[U] ciclosporin; systemic
12.7
6.6
11
9
K03.66
ICD-10 Finland
Tooth plaque
3.6
6.6
29
88
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
7.7
6.5
14
19
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
6.5
48
207
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
71.4
6.5
7
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
71.4
6.5
7
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
71.4
6.5
7
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
6.5
52
233
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
14.8
6.4
10
7
TK800
NOMESCO Finland
Hemodialysis
14.8
6.4
10
7
B99
ICD-10 Finland
Other and unspecified infectious diseases
8.5
6.4
13
16
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
6.3
117
757
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
18.5
6.3
9
5
N02AA05
ATC
oxycodone; systemic
2.6
6.3
47
204
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.3
6
*
L03AA10
ATC
lenograstim; parenteral
+∞
6.3
6
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
6.3
6
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
6.3
6
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
ZXA10
NOMESCO Finland
Bilateral
2.4
6.3
56
266
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.1
6.3
23
60
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
6.2
30
99
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.8
6.1
16
29

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
177
806
3.63
29.15
8.1
5.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
187
900
3.54
27.85
19.2
6.9
inr
1.5
1.2
1.67
40
269
(3006504) Eosinophils/100 leukocytes in Blood
209
1170
3.20
22.54
9.3
5.6
%
2.9
2.8
0.32
198
1087
(3019069) Monocytes/100 leukocytes in Blood
210
1180
3.20
22.48
9.6
5.9
%
8.7
8.4
0.55
200
1108
(3022096) Basophils/100 leukocytes in Blood
205
1137
3.17
22.43
9.5
5.7
%
0.6
0.6
0.24
195
1057
(3023368) Bacteria identified in Blood by Culture
136
610
3.11
21.48
6.2
3.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
211
1217
3.09
21.03
9.7
5.7
%
27.1
29.1
1.53
199
1136
(3018010) Neutrophils/100 leukocytes in Blood
206
1200
2.96
19.66
8.5
5.6
%
57.9
56.3
1.09
195
1127
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
78
263
3.59
19.48
4.2
4.2
u/l
243.6
232.1
0.54
73
250
(3013115) Eosinophils [#/volume] in Blood
216
1309
2.94
18.81
9.7
5.8
e9/l
0.2
0.2
0.32
184
1159
(3006315) Basophils [#/volume] in Blood
211
1264
2.91
18.76
8.7
5.5
e9/l
0.0
0.0
0.04
183
1100
(3001604) Monocytes [#/volume] in Blood
209
1259
2.85
18.15
8.8
5.5
e9/l
0.6
0.6
0.87
184
1091
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
643
2.84
18.13
3.4
2.8
ng/l
2353.9
1426.3
0.86
120
528
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
207
1250
2.81
17.74
10.1
5.6
umol/l
12.3
11.6
0.21
198
1180
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
269
1900
3.41
16.70
12.0
6.3
u/l
84.4
78.2
1.22
256
1766
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
317
3.12
16.19
4.2
2.2
%
21.9
23.2
0.35
72
281
(3019198) Lymphocytes [#/volume] in Blood
209
1304
2.69
16.18
9.1
5.5
e9/l
1.9
2.1
0.41
183
1158
(3042936) Bacteria identified in Isolate by Culture
84
333
3.05
15.85
2.6
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
91
384
2.90
15.30
7.8
3.0
mmol/l
0.8
0.8
0.06
85
366
(3004789) Transferrin [Mass/volume] in Serum or Plasma
84
340
2.98
15.22
3.9
2.1
g/l
2.2
2.4
2.00
79
311
(3020779) Urea [Moles/volume] in Serum or Plasma
57
183
3.56
15.13
14.3
5.7
mmol/l
11.1
8.6
1.39
57
175
(3013650) Neutrophils [#/volume] in Blood by Automated count
225
1488
2.66
14.94
13.8
8.6
e9/l
4.2
4.1
0.27
197
1300
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
608
2.61
14.75
3.0
2.0
mg/l
3.3
3.0
0.53
105
524
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
192
1186
2.51
14.61
13.9
6.2
mmol/l
1.2
1.2
0.37
169
1011
(3024561) Albumin [Mass/volume] in Serum or Plasma
169
1000
2.44
13.92
8.6
3.9
g/l
34.2
35.7
2.57
162
934
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
179
1087
2.44
13.91
13.3
5.5
mmol/l
1.2
1.2
0.43
168
984
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
98
4.26
13.68
1.8
1.9
g/l
1.8
1.5
0.93
32
91
(3021589) Normoblasts [#/volume] in Blood
186
1158
2.42
13.55
10.4
8.4
e9/l
0.0
0.0
0.44
149
946
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
369
2.77
13.37
2.5
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
164
974
2.38
13.19
2.5
1.9
pmol/l
98.4
94.3
0.55
93
498
(3000991) Gas panel - Venous blood
58
207
3.19
12.93
13.9
6.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
165
990
2.35
12.87
3.4
2.2
nmol/l
74.9
75.8
0.17
156
885
(3044640) Blood type and Crossmatch panel - Blood
137
759
2.39
12.83
4.0
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
96
454
2.58
12.66
5.6
3.0
ng/l
176.2
199.8
0.06
85
331
(3013826) Glucose [Moles/volume] in Serum or Plasma
208
1394
2.37
12.34
9.9
4.4
mmol/l
6.9
6.6
1.73
198
1292
(3001122) Ferritin [Mass/volume] in Serum or Plasma
180
1135
2.31
12.33
4.1
2.6
ug/l
130.4
102.7
0.85
170
1040
(40758558) Short blood count panel - Blood
121
653
2.36
11.85
9.7
6.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
140
812
2.27
11.50
4.2
3.0
u/l
36.2
32.2
0.24
133
776
(3026493) Urate [Moles/volume] in Serum or Plasma
112
591
2.37
11.49
4.2
2.7
umol/l
6900.5
6917.4
0.00
99
513
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
106
549
2.38
11.32
3.5
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
429
2.48
11.11
3.5
2.8
e6/l
2.1
2.6
0.32
45
242
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
123
687
2.27
10.95
2.8
2.1
u/l
125.7
314.5
1.09
117
659
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
296
2.69
10.94
1.8
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
64
4.51
10.78
4.3
2.5
u/ml
0.3
0.3
0.83
17
31
(4035726)
52
198
2.94
10.28
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
136
812
2.16
10.09
4.5
3.0
e6/l
19.9
74.9
2.45
103
626
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
257
2.69
9.97
2.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
65
285
2.60
9.80
7.2
2.8
%
1.6
1.7
0.37
55
259
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
152
3.11
9.66
9.2
4.8
mmol/l
1.8
1.9
0.08
37
112
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
255
2.66
9.62
2.1
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
67
301
2.54
9.60
10.7
6.5
mmol/l
105.0
104.5
0.34
67
296
(3019309) Folate [Moles/volume] in Red Blood Cells
83
413
2.36
9.51
1.8
1.8
nmol/l
1152.9
1224.7
0.27
65
316
(3018095) Leukocytes [#/volume] in Urine
149
940
2.08
9.41
5.4
3.5
e6/l
90.6
94.4
0.03
106
665
(36304419) Bacteria [Presence] in Urine
122
715
2.13
9.36
4.3
2.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
179
2.90
9.26
1.3
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
123
726
2.12
9.24
3.3
2.4
u/l
52.6
54.8
0.25
115
663
(3002032) Base excess in Venous blood by calculation
55
229
2.69
9.17
8.7
4.4
mmol/l
2.4
1.9
0.34
50
165
(3030467) Casts [#/volume] in Urine by Automated count
124
736
2.11
9.16
4.4
3.0
e6/l
0.3
0.4
0.10
92
550
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
140
3.12
9.13
1.9
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
116
3.26
8.73
7.8
5.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
140
883
2.03
8.67
4.9
3.3
ng/l
40.6
43.3
0.09
95
571
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
44
170
2.84
8.43
1.7
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
51
214
2.64
8.35
12.5
6.7
mmol/l
1.4
1.3
0.14
51
204
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
73
3.78
8.31
2.5
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
38
4.96
8.21
4.1
2.4
e9/l
3.7
3.9
0.20
18
38
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
167
1141
1.95
8.04
6.5
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
95
532
2.11
8.02
3.3
2.6
mosm/kgh2o
516.9
572.4
1.48
83
450
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
39
4.83
7.98
4.7
2.5
%
56.2
55.3
0.12
18
39
(3015377) Calcium [Moles/volume] in Serum or Plasma
133
844
1.97
7.93
4.8
2.8
mmol/l
2.4
2.4
0.19
118
737
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
283
2.37
7.65
4.7
2.5
umol/l
11.1
10.1
0.08
48
238
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
104
3.19
7.58
17.2
8.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
83
451
2.13
7.52
3.6
2.6
e6/l
0.5
0.9
1.98
39
260
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
217
1641
1.97
7.52
4.4
2.8
u/l
61.3
44.8
1.89
206
1534
(3003396) Base excess in Arterial blood by calculation
56
258
2.41
7.52
11.3
6.6
mmol/l
1.6
1.1
0.35
49
198
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
59
3.93
7.49
1.9
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
142
937
1.92
7.42
5.3
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
228
1764
1.98
7.26
6.2
4.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
35
4.76
7.01
1.9
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
217
1663
1.92
6.96
7.0
4.2
e6/l
444.0
241.3
—
5
25
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
92
540
1.98
6.68
2.9
1.9
mg/l
1.2
1.2
0.01
70
412
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
47
211
2.44
6.66
4.6
2.2
g/l
0.2
0.2
0.28
41
193
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
80
3.30
6.59
1.5
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
117
749
1.88
6.54
8.3
3.6
ph
7.4
7.4
1.41
15
129
(3009542) Hematocrit [Volume Fraction] of Blood
281
2390
2.30
6.34
31.8
13.5
%
37.7
40.0
3.00
223
1787
(44806118)
12
22
5.63
6.33
2.9
1.5
—
—
—
0
0
(44790049)
12
22
5.63
6.33
2.9
1.5
—
—
—
0
0
(44790048)
12
22
5.63
6.33
2.9
1.5
—
—
—
0
0
(44790047)
12
22
5.63
6.33
2.9
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
115
740
1.86
6.28
3.7
3.0
mmol/l
7.7
7.7
0.01
95
625
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
30
4.83
6.27
12.4
3.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
42
184
2.47
6.26
4.5
2.4
g/l
10.1
10.2
0.05
42
173
(3021960) Folate [Moles/volume] in Serum or Plasma
94
568
1.92
6.22
1.8
1.5
nmol/l
20.7
21.4
0.17
85
475
(3007853) Bacteria identified in Skin by Aerobe culture
56
280
2.21
6.19
2.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
73
405
2.03
6.16
1.8
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
281
2400
2.26
6.11
23.1
11.3
ml/min/173m2
81.6
83.6
0.57
245
1944
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
27
4.97
6.02
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
117
766
1.82
5.99
4.9
3.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
16
6.42
5.99
1.7
2.7
—
—
—
0
0
(3000492) Spirometry study
46
216
2.32
5.89
1.8
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
90
548
1.89
5.77
3.5
2.4
e6/l
7.7
5.3
0.65
75
473
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
239
2.24
5.74
3.0
2.2
u/l
30.7
30.6
0.02
44
193
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
305
2723
2.95
5.63
16.8
9.1
u/l
26.2
25.3
0.44
300
2625
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
7
13.17
5.61
3.3
1.0
ug/l
82.4
79.0
—
9
7
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
57
3.48
5.53
1.9
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
63
3.32
5.41
1.5
1.3
iu/ml
0.1
0.1
—
6
12
(3023520) Reticulocytes [#/volume] in Blood
43
204
2.28
5.37
4.1
3.0
e9/l
71.8
66.3
0.32
34
159
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
75
3.07
5.25
1.4
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
49
3.61
5.25
3.6
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
232
1898
1.78
5.14
5.8
3.6
mm/h
15.3
11.3
2.95
215
1737
(3004588) Protein electrophoresis panel - Serum or Plasma
34
148
2.45
5.14
1.5
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
700
1.76
5.14
5.0
3.9
mg/mmol
29.4
12.1
0.87
77
442
(3044927) Protein electrophoresis panel - Urine
10
19
5.40
5.07
1.3
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
214
1716
1.72
5.05
5.1
3.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
85
2.84
4.79
1.4
1.9
g/l
10.5
10.0
0.36
18
79
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
92
2.74
4.68
1.4
1.8
g/l
8.3
7.5
0.63
15
76
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
92
2.74
4.68
1.4
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
92
2.74
4.68
1.4
1.8
g/l
3.8
3.6
0.33
15
73
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
291
2588
2.19
4.63
30.0
12.1
mg/l
25.4
23.2
0.59
262
1962
(21494815) CD4 cells/100 lymphocytes in Specimen
10
21
4.88
4.56
1.5
2.6
—
39.4
—
0
5
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
8
10.21
4.54
1.6
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
285
2520
2.06
4.53
5.3
4.6
mmol/l
2.6
2.8
1.74
271
2321
(3012516) Albumin [Mass/volume] in Urine
98
657
1.70
4.41
3.8
3.1
mg/l
704.4
171.1
0.47
69
431
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
9
9.08
4.30
1.3
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
233
1952
1.68
4.27
4.9
3.8
pmol/l
14.7
14.7
0.12
213
1768
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
51
3.25
4.27
3.7
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
37
3.62
4.09
5.2
2.7
—
—
—
0
0
(3019225) pH of Specimen
40
206
2.07
4.09
8.3
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
47
257
1.97
4.08
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
7
10.18
4.03
1.4
3.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
7
10.18
4.03
1.6
3.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
14
6.58
4.01
4.1
2.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
82
2.67
3.97
2.6
3.5
g/l
0.5
0.2
—
10
33
(3037756) Immunofixation for Serum or Plasma
14
43
3.36
3.95
1.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
38
3.52
3.94
3.6
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
268
2354
1.79
3.90
6.2
4.5
mu/l
2.0
1.9
0.57
258
2150
(3023183) Ammonium ion [Moles/volume] in Plasma
15
49
3.16
3.86
5.4
3.5
umol/l
26.0
38.1
1.41
15
44
(3017181) Myelocytes/100 leukocytes in Blood
35
176
2.11
3.81
7.2
5.2
%
1.1
0.8
0.35
18
62
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
34
3.63
3.80
2.3
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
55
3.01
3.79
2.0
2.4
g/l
122.3
135.6
—
8
37
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
8
8.91
3.79
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
8
8.91
3.79
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
50
3.10
3.74
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
50
3.10
3.74
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
25
4.10
3.72
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
86
2.54
3.63
1.4
1.9
g/l
3.4
3.1
0.36
15
74
(3019550) Sodium [Moles/volume] in Serum or Plasma
289
2615
1.95
3.58
34.8
13.8
mmol/l
139.4
139.7
1.03
283
2542
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
9
7.92
3.57
2.1
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
259
2272
1.69
3.56
7.3
5.4
mmol/mol
41.1
39.3
1.84
247
2115
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
26
3.94
3.55
2.3
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
26
3.94
3.55
1.5
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
17
5.41
3.53
3.4
1.6
%
94.2
106.8
—
9
17
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
276
2466
1.79
3.51
4.6
4.1
mmol/l
4.4
4.6
2.57
261
2298
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
36
3.42
3.51
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
6
10.16
3.51
4.2
1.3
—
—
—
0
0
(3013512) EKG study
95
666
1.60
3.49
5.5
3.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
275
2457
1.78
3.47
4.5
4.0
mmol/l
1.4
1.5
3.71
259
2267
(3037522) Nuclear Ab [Titer] in Serum
54
326
1.79
3.46
1.2
1.3
titre
367.3
446.7
0.26
11
72
(3023103) Potassium [Moles/volume] in Serum or Plasma
289
2623
1.92
3.43
35.4
13.8
mmol/l
4.0
4.0
0.59
282
2548
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
42
3.18
3.41
1.5
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
163
2.07
3.38
7.7
5.4
%
0.2
0.2
0.15
18
54
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
27
3.79
3.38
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
23
102
2.35
3.38
3.0
2.2
u/l
41.5
39.5
0.12
18
95
(3002256) Pathology report gross observation
52
313
1.79
3.36
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
32
3.52
3.36
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
48
3.00
3.34
7.6
6.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
19
4.84
3.26
1.6
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
49
2.94
3.23
1.6
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
297
2731
2.02
3.22
24.3
11.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
28
3.65
3.22
3.1
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
1013
1.51
3.20
2.4
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
266
2374
1.66
3.13
4.2
3.7
mmol/l
1.4
1.2
1.62
248
2182
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
93
2.34
3.10
3.4
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
56
2.76
3.10
1.5
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
49
297
1.77
3.10
1.9
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
34
3.31
3.08
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
8
7.61
3.06
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
155
2.03
3.06
6.7
5.5
%
0.0
0.0
0.00
16
44
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
13
45
2.97
3.06
1.5
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
21
4.38
3.01
1.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
40
3.08
3.00
2.8
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
88
2.36
3.00
2.5
1.7
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
5
10.13
2.99
5.6
5.0
mmol/l
24.3
23.8
—
5
5
(40768446) Kidney Pathology biopsy report
5
5
10.13
2.99
1.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
74
506
1.60
2.98
2.4
1.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
41
239
1.82
2.95
3.0
1.9
nmol/l
395.5
367.2
0.34
41
217
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
76
2.45
2.95
5.7
4.0
%
0.9
0.9
0.01
18
71
(3025941) Bacteria identified in Stool by Culture
29
151
2.01
2.91
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
520
1.57
2.84
1.7
1.4
g/l
2.5
2.3
0.19
46
318
(40768443) Skin Pathology biopsy report
19
84
2.34
2.83
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
154
1242
1.46
2.82
5.1
3.6
estimate
0.0
0.0
0.00
21
246
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
23
3.99
2.79
3.1
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
48
2.78
2.75
1.5
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
68
466
1.58
2.70
4.3
2.6
mmol/l
2.4
2.5
0.01
60
412
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
24
3.83
2.69
1.1
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
29
156
1.94
2.67
4.7
5.1
%
0.9
0.3
1.22
12
41
(40768797) Stomach Pathology biopsy report
52
335
1.66
2.65
1.4
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
75
2.34
2.55
5.8
3.9
%
1.5
1.6
0.06
17
69
(3021601) Nitrite [Presence] in Urine by Test strip
153
1253
1.42
2.48
8.6
4.9
estimate
0.0
0.0
0.00
23
243
(36660697) Celiac disease serology panel - Serum
34
198
1.80
2.47
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
12
5.07
2.41
1.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
46
2.67
2.38
1.5
1.1
u/ml
370.2
176.0
—
6
23
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
8
6.33
2.38
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
65
2.37
2.35
1.9
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
72
2.29
2.31
3.9
2.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
23
3.54
2.28
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
36
2.83
2.22
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
9
5.62
2.22
1.2
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
9
5.62
2.22
4.2
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
48
2.56
2.21
2.1
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
24
3.39
2.19
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
116
1.96
2.16
1.7
2.0
u/l
7156.5
5623.3
—
6
37
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
19
3.74
2.16
3.4
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
19
3.74
2.16
1.3
2.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
25
3.25
2.11
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
25
3.25
2.11
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
152
1269
1.37
2.10
5.8
3.7
estimate
0.0
0.0
0.00
24
236
(3013727) Leukocytes other/100 leukocytes in Blood
5
10
5.06
2.08
19.6
4.9
%
48.2
45.0
—
5
10
(40768441) Liver Pathology biopsy report
6
15
4.05
2.05
2.8
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
15
4.05
2.05
4.5
3.1
umol/l
25.3
27.0
—
6
15
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
63
2.28
2.04
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
77
575
1.44
2.02
1.5
1.3
u/ml
2.2
0.9
0.71
17
147
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
32
2.86
2.01
3.0
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
21
3.38
1.97
1.9
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
71
2.17
1.95
1.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
6
16
3.80
1.94
4.5
2.4
umol/l
1.9
1.6
—
6
16
(3023419) Bacteria identified in Sputum by Culture
7
22
3.23
1.89
2.3
2.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
17
3.57
1.84
1.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.21
1.83
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
35
2.62
1.81
5.3
1.9
u/ml
50.7
126.8
—
9
30
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
35
2.62
1.81
2.2
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
265
2450
1.44
1.79
6.3
4.2
mmol/l
6.1
5.9
2.17
248
2243
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
18
3.38
1.75
16.5
4.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
18
3.38
1.75
3.7
2.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
277
1.55
1.75
3.7
4.1
%
30.5
31.3
0.12
28
180
(3045424) Erythrocytes [Presence] in Urine
8
30
2.71
1.73
1.1
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
30
2.71
1.73
2.4
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
30
2.71
1.73
2.5
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
24
2.96
1.73
1.1
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
55
2.23
1.69
2.8
3.8
mg/l
37.0
32.6
—
7
35
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
19
3.20
1.67
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
19
3.20
1.67
1.0
1.2
—
—
—
0
0
(4062490)
7
25
2.84
1.66
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
25
2.84
1.66
1.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
13
63
2.11
1.62
1.2
3.5
—
1.1
—
0
5
(3011397) Hemoglobin [Presence] in Urine by Test strip
73
563
1.38
1.59
5.3
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
145
1.71
1.59
1.7
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
20
3.04
1.59
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
492
1.40
1.58
1.7
1.7
pmol/l
396.2
433.0
0.90
51
409
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
195
1735
1.31
1.58
3.2
3.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
(4198724)
5
15
3.37
1.53
1.2
2.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
27
2.63
1.52
3.0
2.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
51
2.20
1.52
2.3
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
73
570
1.36
1.48
7.6
5.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
141
1.68
1.46
5.5
4.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
28
2.53
1.46
2.0
2.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
88
1.86
1.44
2.2
1.8
—
—
—
0
0
(4306422)
9
39
2.34
1.44
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
22
2.76
1.44
1.2
3.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
22
2.76
1.44
2.0
2.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
74
1.93
1.41
1.9
1.2
—
—
—
0
0
(4268621)
7
29
2.44
1.40
1.9
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
135
1.68
1.40
5.6
3.5
—
—
—
0
0
(4010399)
27
175
1.59
1.39
1.6
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
17
2.97
1.36
2.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
90
1.82
1.35
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
47
2.16
1.35
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
43
2.12
1.31
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
18
2.80
1.29
6.2
8.2
mmol/l
0.7
0.6
—
5
18
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
147
1.61
1.27
1.4
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
25
2.43
1.25
4.7
1.6
ug/l
21.5
17.0
—
6
25
(40760888) Immunoglobulin light chains.free panel - Serum
9
45
2.03
1.24
1.2
4.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
189
1.53
1.23
2.5
2.5
ml/min/173m2
61.0
68.2
0.30
15
76
(42529406) Shigella sp [Presence] in Stool by Culture
16
93
1.76
1.23
1.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
37
2.19
1.22
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
88
726
1.29
1.21
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
92
765
1.28
1.19
4.6
4.9
ug/l
3.3
2.4
0.34
84
683
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
11
57
1.96
1.18
2.4
2.0
mmol/l
3.8
3.7
0.18
11
52
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
39
2.08
1.16
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
80
1.78
1.14
7.4
4.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
88
1.74
1.13
1.5
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
40
2.02
1.13
8.9
7.3
%
75.3
65.5
—
8
40
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
73
1.81
1.12
1.5
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
81
1.76
1.10
1.7
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
69
558
1.30
1.10
2.0
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
41
1.97
1.09
5.1
2.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
5.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
5.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
5.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
52
1.95
1.07
1.5
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
8
151
0.52
1.05
2.9
3.0
u/ml
97.1
53.3
—
8
144
(3017732) Neutrophils [#/volume] in Blood
24
163
1.51
1.05
1.7
2.6
e9/l
3.6
3.9
0.26
15
133
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
46
1.98
1.04
3.6
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
60
1.86
1.04
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
223
1.43
1.03
3.7
3.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
47
1.94
1.03
3.6
2.8
mmol/l
104.8
105.4
—
9
47
(3041354) Potassium [Moles/volume] in Venous blood
9
47
1.94
1.03
3.6
2.8
mmol/l
4.0
4.0
—
9
47
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
76
632
1.26
0.98
1.7
1.7
mmol/l
1.3
1.4
0.11
71
540
(3008898) HLA-B27 [Presence]
6
116
0.51
0.96
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
87
1.64
0.89
2.9
3.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
418
1.29
0.88
1.2
1.3
iu/ml
26.3
39.0
—
9
139
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
30
2.02
0.87
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
44
1.84
0.86
2.9
3.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
31
1.95
0.85
1.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
32
1.89
0.82
1.5
2.4
pg
34.8
32.9
—
6
32
(3016879) Cocaine [Presence] in Urine
17
114
1.52
0.81
1.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
149
0.59
0.81
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
107
1.52
0.77
1.6
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
275
0.71
0.74
1.6
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.2
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
26
1.94
0.71
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
26
1.94
0.71
2.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.2
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
118
1.47
0.71
2.1
1.6
mg/l
4.0
2.6
0.52
17
89
(40768793) Breast Pathology biopsy report
9
58
1.57
0.70
1.6
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
23
170
1.38
0.69
1.3
1.3
—
49.4
—
0
12
(3028707) Methadone [Presence] in Urine by Screen method
10
61
1.66
0.69
1.9
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
154
1.39
0.67
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
79
898
0.84
0.65
3.1
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
87
1.51
0.64
1.8
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
39
317
1.26
0.63
2.4
2.0
ug/g
194.5
123.9
0.40
32
247
(3028271) Lactate [Moles/volume] in Capillary blood
5
30
1.68
0.61
2.4
1.8
mmol/l
0.9
1.8
—
5
30
(3028300) Cannabinoids [Presence] in Urine
17
122
1.42
0.61
1.8
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
122
1.42
0.61
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
122
1.42
0.61
1.8
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
206
0.72
0.57
8.9
3.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
250
0.75
0.56
1.2
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
37
1.63
0.56
4.3
3.1
u/ml
25.0
21.3
—
6
37
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
42
351
1.23
0.55
2.6
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
98
0.61
0.53
1.7
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
99
0.60
0.52
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
684
0.85
0.51
6.3
3.9
estimate
0.0
0.0
0.00
22
233
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
198
1.28
0.51
2.2
2.3
—
18.0
—
0
11
(3027944) Amphetamines [Presence] in Urine
16
120
1.35
0.47
1.6
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
82
0.60
0.46
8.8
4.3
mmol/l
3.7
3.9
—
5
75
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
174
1.28
0.46
1.4
1.3
—
—
—
0
0
(4034850)
5
83
0.60
0.46
34.6
8.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
83
0.60
0.46
1.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
80
725
1.14
0.42
5.6
3.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
18
142
1.28
0.39
10.3
6.9
mmol/l
26.1
24.2
0.74
18
133
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
98
1.34
0.38
2.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
8
112
0.71
0.38
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
42
1.44
0.35
1.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
13
101
1.30
0.32
1.1
1.3
—
1.6
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
382
1.14
0.31
2.9
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
218
0.82
0.31
2.0
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
157
1.22
0.30
6.3
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
471
1.12
0.29
2.8
3.0
ug/l
0.9
0.8
0.35
46
317
(3023511) Choriogonadotropin [Units/volume] in Urine
10
76
1.33
0.28
1.5
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
74
0.67
0.26
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
74
0.67
0.26
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
74
0.67
0.26
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
74
0.67
0.26
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
233
0.85
0.24
1.6
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
84
0.71
0.24
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(44806420)
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
8.5
—
0
13
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(44813793)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
285
1.10
0.14
2.5
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(4094501)
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
97
992
0.97
0.07
6.9
3.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
59
571
1.04
0.07
6.4
3.7
kg/l
1.0
1.0
0.61
13
86
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
86
1.05
0.07
1.7
2.5
—
—
—
0
0
(3020891) Body temperature
9
88
1.02
0.07
11.7
5.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
415
0.96
0.06
1.4
1.3
u/ml
1.4
15.4
—
8
156
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
45
437
1.03
0.04
1.4
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
290
0.96
0.03
9.1
6.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
310
0.96
0.03
1.5
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
182
1.05
0.02
1.2
1.2
iu/ml
120.9
126.5
—
7
76
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
167
0.96
0.01
1.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
134
1.05
0.00
2.4
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
172
0.99
0.00
2.1
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
632
1.00
0.00
3.8
4.4
%
22.8
22.0
0.12
33
325
(40761536) Microorganisms panel - Urine sediment
22
221
1.00
0.00
6.1
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
29.9
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
50
1.00
0.00
2.8
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
159.0
—
0
6
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
86
0.93
0.00
1.6
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
1.3
—
0
7
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: Z21_PERSONAL_HISTORY_MEDICAL_TREAT – Personal history of medical treatment

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).